NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LVIS Corporation

LVIS Corporation

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://lviscorp.com/en/

Last Round

Series B

Extension

Jan 11, 2022

Est. Valuation

$109.01M

Total Funding Raised

$17.97M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

LVIS Corporation is a neurotechnology company that develops AI-driven software tools to assist physicians in the diagnosis and treatment of neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

EEG analysismedical AIneurology softwareSaMDsoftware as a medical deviceepilepsy diagnosticsbrain healthclinical decision supportquantitative EEGneurotechdigital healthseizure detectiontelemedicinehealthcare analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LVIS Corporation Comparables

Compare LVIS Corporation with similar companies based on industry and business-model similarity.

LVIS Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Persyst Development Corporation
81%
Neurogram
80%
BESA GmbH
78%

LVIS Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJan 11, 2022

LVIS Corporation Investors

Notable investors and investment history

LVIS Corporation investors
InvestorRounds
SK Inc.Series A
Hico CapitalSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2026

    Launched the NeuroMatch system for managing clinical data.

  • Apr 25, 2026

    Launched the Neuvera Brain Health Institute for EEG studies and neurological care.

LVIS Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LVIS Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LVIS Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range12
Year Founded2013
Last FundingJan 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.